Exosomes: Breast cancer-derived extracellular vesicles; recent key findings and technologies in disease progression, diagnostics, and cancer targeting

Drug Metab Pharmacokinet. 2022 Feb:42:100435. doi: 10.1016/j.dmpk.2021.100435. Epub 2021 Dec 11.

Abstract

Breast cancer is one of the most frequently diagnosed types of cancer in women. Metastasis, particularly to the lungs and brain, increases mortality in breast cancer patients. Recently, breast cancer-related exosomes have received significant attention because of their key role in breast cancer progression. As a result, numerous exosome-based therapeutic tools for diagnosis and treatment have been developed, and their biological and chemical mechanisms have been explored. This review summarizes up-to-date advanced key findings and technologies in breast cancer progression, diagnostics, and targeting. We focused on recent research on the basic biology of exosomes and disease-related exosomal genes and proteins, as well as their signal transduction in cell-to-cell communications, diagnostic markers, and exosome-based antibreast cancer technologies. We also paid special attention to technologies employing exosomes modified with functional peptides for the targeted delivery of therapeutic and diagnostic agents.

Keywords: Breast cancer; Cell-to-cell communication; Exosomes; Extracellular vesicles; Intracellular delivery; Metastasis.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms* / diagnosis
  • Cell Communication
  • Disease Progression
  • Exosomes* / genetics
  • Female
  • Humans
  • Signal Transduction